Bare Financial Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7K Buy
118
+39
+49% +$3.27K ﹤0.01% 557
2026
Q1
$6.33K Buy
79
+19
+32% +$1.57K ﹤0.01% 542
2025
Q4
$5.12K Buy
60
+7
+13% +$574 ﹤0.01% 531
2025
Q3
$4.12K Buy
53
+6
+13% +$469 ﹤0.01% 618
2025
Q2
$3.68K Buy
47
+38
+422% +$2.83K ﹤0.01% 615
2025
Q1
$652 Buy
+9
New +$644 ﹤0.01% 666

Other funds holding EW

Bare Financial Services's EW Position: Q2 2026 in Review

Bare Financial Services increased its Edwards Lifesciences (EW) stake by 49% in Q2 2026, buying an estimated $3.27K and bringing the position to 118 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #557.

Bare Financial Services first reported a position in EW in Q1 2025 and has held it in 6 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Bare Financial Services held 118 shares of Edwards Lifesciences worth $10.7K as of Q2 2026.
  • Bare Financial Services bought 39 Edwards Lifesciences shares in Q2 2026, an estimated $3.27K.
  • Edwards Lifesciences made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #557 holding.
  • Bare Financial Services first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 6 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.